Abnova (Taiwan) Corporation (4133.TW)
TWD 26.4
(0.96%)
TWD 26.4
(0.96%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 408.3 Million TWD | 3.09% |
| 2022 | 396.07 Million TWD | -4.74% |
| 2021 | 415.79 Million TWD | -8.74% |
| 2020 | 455.6 Million TWD | -0.69% |
| 2019 | 458.78 Million TWD | -7.26% |
| 2018 | 494.68 Million TWD | -12.84% |
| 2017 | 567.57 Million TWD | -2.35% |
| 2016 | 581.23 Million TWD | -2.58% |
| 2015 | 596.62 Million TWD | -2.4% |
| 2014 | 611.31 Million TWD | 4.3% |
| 2013 | 586.09 Million TWD | 1.65% |
| 2012 | 576.56 Million TWD | 4.64% |
| 2011 | 550.98 Million TWD | 4.46% |
| 2010 | 527.46 Million TWD | 11.98% |
| 2009 | 471.03 Million TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 415.6 Million TWD | 1.79% |
| 2024 Q2 | 423.57 Million TWD | 1.92% |
| 2023 Q3 | 401.16 Million TWD | 0.9% |
| 2023 Q2 | 397.59 Million TWD | 0.71% |
| 2023 Q4 | 408.3 Million TWD | 1.78% |
| 2023 Q1 | 394.77 Million TWD | -0.33% |
| 2023 FY | 408.3 Million TWD | 3.09% |
| 2022 Q3 | 395.95 Million TWD | -1.22% |
| 2022 FY | 396.07 Million TWD | -4.74% |
| 2022 Q4 | 396.07 Million TWD | 0.03% |
| 2022 Q2 | 400.84 Million TWD | -1.44% |
| 2022 Q1 | 406.7 Million TWD | -2.18% |
| 2021 Q2 | 440.72 Million TWD | -1.9% |
| 2021 Q4 | 415.79 Million TWD | -3.5% |
| 2021 Q1 | 449.28 Million TWD | -1.39% |
| 2021 FY | 415.79 Million TWD | -8.74% |
| 2021 Q3 | 430.88 Million TWD | -2.23% |
| 2020 Q3 | 459.94 Million TWD | 0.39% |
| 2020 FY | 455.6 Million TWD | -0.69% |
| 2020 Q1 | 458.94 Million TWD | 0.04% |
| 2020 Q2 | 458.14 Million TWD | -0.18% |
| 2020 Q4 | 455.6 Million TWD | -0.94% |
| 2019 FY | 458.78 Million TWD | -7.26% |
| 2019 Q4 | 458.78 Million TWD | -1.21% |
| 2019 Q3 | 464.41 Million TWD | -1.6% |
| 2019 Q1 | 479.76 Million TWD | -3.02% |
| 2019 Q2 | 471.96 Million TWD | -1.63% |
| 2018 FY | 494.68 Million TWD | -12.84% |
| 2018 Q2 | 547.51 Million TWD | -0.83% |
| 2018 Q3 | 540.3 Million TWD | -1.32% |
| 2018 Q1 | 552.09 Million TWD | -2.73% |
| 2018 Q4 | 494.68 Million TWD | -8.44% |
| 2017 Q4 | 567.57 Million TWD | -0.69% |
| 2017 Q2 | 568.21 Million TWD | -2.31% |
| 2017 FY | 567.57 Million TWD | -2.35% |
| 2017 Q1 | 581.62 Million TWD | 0.07% |
| 2017 Q3 | 571.54 Million TWD | 0.59% |
| 2016 Q3 | 578.68 Million TWD | -0.57% |
| 2016 FY | 581.23 Million TWD | -2.58% |
| 2016 Q4 | 581.23 Million TWD | 0.44% |
| 2016 Q2 | 582.03 Million TWD | -1.28% |
| 2016 Q1 | 589.57 Million TWD | -1.18% |
| 2015 FY | 596.62 Million TWD | -2.4% |
| 2015 Q4 | 596.62 Million TWD | -0.14% |
| 2015 Q3 | 597.45 Million TWD | -1.17% |
| 2015 Q2 | 604.5 Million TWD | 1.11% |
| 2015 Q1 | 597.87 Million TWD | -2.2% |
| 2014 Q3 | 598.83 Million TWD | 0.72% |
| 2014 FY | 611.31 Million TWD | 4.3% |
| 2014 Q4 | 611.31 Million TWD | 2.09% |
| 2014 Q2 | 594.54 Million TWD | 0.36% |
| 2014 Q1 | 592.39 Million TWD | 1.08% |
| 2013 Q3 | 584.78 Million TWD | 0.86% |
| 2013 Q4 | 586.09 Million TWD | 0.22% |
| 2013 FY | 586.09 Million TWD | 1.65% |
| 2013 Q1 | 576.51 Million TWD | -0.01% |
| 2013 Q2 | 579.81 Million TWD | 0.57% |
| 2012 Q1 | 560.06 Million TWD | 1.65% |
| 2012 Q4 | 576.56 Million TWD | 1.04% |
| 2012 FY | 576.56 Million TWD | 4.64% |
| 2012 Q2 | 567.71 Million TWD | 1.37% |
| 2012 Q3 | 570.65 Million TWD | 0.52% |
| 2011 Q4 | 550.98 Million TWD | 2.2% |
| 2011 Q1 | 529.4 Million TWD | 0.37% |
| 2011 Q2 | 531.68 Million TWD | 0.43% |
| 2011 Q3 | 539.1 Million TWD | 1.4% |
| 2011 FY | 550.98 Million TWD | 4.46% |
| 2010 Q4 | 527.46 Million TWD | 0.0% |
| 2010 FY | 527.46 Million TWD | 11.98% |
| 2009 FY | 471.03 Million TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Apex Biotechnology Corp. | 747.71 Million TWD | 45.393% |
| Sinphar Pharmaceutical Co.,Ltd. | 839.19 Million TWD | 51.346% |
| Panion & Bf Biotech Inc. | 538.09 Million TWD | 24.121% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 1.21 Billion TWD | 66.285% |
| GenMont Biotech Incorporation | 88.11 Million TWD | -363.358% |
| Adimmune Corporation | 526.4 Million TWD | 22.436% |
| Tanvex BioPharma, Inc. | 108.28 Million TWD | -277.062% |
| Polaris Group | 36.35 Million TWD | -1023.097% |
| Energenesis Biomedical CO.,LTD. | 733 Thousand TWD | -55602.865% |
| UnicoCell Biomed Co., Ltd. | 5.45 Million TWD | -7390.405% |
| PELL Bio-Med Technology Co. Ltd. | 3.76 Million TWD | -10750.438% |